A closed-end fund managed by BlackRock, BSTZ focuses on investing in equity securities of companies engaged in the science and technology sectors, including biotechnology, software, and semiconductors. It is actively managed and leverages BlackRock's expertise in identifying growth opportunities in innovation-driven industries.
2 members of Congress have disclosed 4 trades in BlackRock Science and Technology Trust II (BSTZ), a Technology company. The buy/sell breakdown shows 3 purchases versus 1 sale, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2020-02-22 | Thomas R Carper | sell | $1K – $15K |
| 2019-11-19 | John Hoeven | buy | $100K – $250K |
| 2019-06-26 | Thomas R Carper | buy | $1K – $15K |
| 2019-06-26 | John Hoeven | buy | $100K – $250K |